Related Party Transactions	9 Months Ended
Sep. 30, 2018
Related Party Transactions [Abstract]
Related Party Transactions	Included in advances – related parties are amounts to the Company’s former CFO and Chairman of the Board of $50,000 at September 30, 2018 and December 31, 2017. Also included in advances – related parties are amounts of 32,105 Euros, ($37,275 as September 30, 2018) to Ms. Michaela Ott, stockholder and former CEO of the Company, related to two short term bridge loans. The Company has made arrangements to settle these obligations evenly over a 24 month period, starting on October 31, 2017. In addition, the Company settled obligations related to accrued salaries, vacation and related expenses totaling $152,000 owed to Mr. Michael Ott, stockholder and former COO of the Company, and Ms. Ott. The Company made an upfront payment to each Mr. and Ms. Ott of $6,750 and will pay the remaining amount owed over a period of 18 months starting in October 2017. The Company signed additional agreements to settle the debt owed from the US entity when the wages earned versus the German entity. The Company has paid Ms. Ott $37,275 during the nine months ended September 30, 2018 related to the amount owed. The balance due to Ms. Ott at September 30, 2018 is $37,275 related to the wages owed. During the nine months ended September 30, 2018, the Company has paid Mr. Ott $9,544 and the remaining balance outstanding at September 30, 2018 was $41,356. The Company has stopped payments to Mr. Ott, pending the outcome of legal proceedings (see Note 7 below). Accrued salaries, vacation and related expenses at September 30, 2018 and December 31, 2017, includes amounts for the former CFO of approximately $1.1 million, which is included in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheets. See Note 7 for further discussion regarding the legal proceedings with the Company’s former CFO. During the nine months ended September 30, 2018, the Company entered into a subordinated convertible note and 2018 convertible notes (see Note 4). The Company received $2,322,500 of gross proceeds and converted $223,000 of accrued liabilities from related parties, including board members, and issued 33,940,000 shares of common stock.

Related Party Transactions

9 Months Ended

Sep. 30, 2018

Included in advances – related parties are amounts to the Company’s former CFO and Chairman of the Board of $50,000 at September 30, 2018 and December 31, 2017. Also included in advances – related parties are amounts of 32,105 Euros, ($37,275 as September 30, 2018) to Ms. Michaela Ott, stockholder and former CEO of the Company, related to two short term bridge loans. The Company has made arrangements to settle these obligations evenly over a 24 month period, starting on October 31, 2017. In addition, the Company settled obligations related to accrued salaries, vacation and related expenses totaling $152,000 owed to Mr. Michael Ott, stockholder and former COO of the Company, and Ms. Ott. The Company made an upfront payment to each Mr. and Ms. Ott of $6,750 and will pay the remaining amount owed over a period of 18 months starting in October 2017. The Company signed additional agreements to settle the debt owed from the US entity when the wages earned versus the German entity. The Company has paid Ms. Ott $37,275 during the nine months ended September 30, 2018 related to the amount owed. The balance due to Ms. Ott at September 30, 2018 is $37,275 related to the wages owed. During the nine months ended September 30, 2018, the Company has paid Mr. Ott $9,544 and the remaining balance outstanding at September 30, 2018 was $41,356. The Company has stopped payments to Mr. Ott, pending the outcome of legal proceedings (see Note 7 below).

Accrued salaries, vacation and related expenses at September 30, 2018 and December 31, 2017, includes amounts for the former CFO of approximately $1.1 million, which is included in accounts payable and accrued expenses in the accompanying condensed consolidated balance sheets. See Note 7 for further discussion regarding the legal proceedings with the Company’s former CFO.

During the nine months ended September 30, 2018, the Company entered into a subordinated convertible note and 2018 convertible notes (see Note 4). The Company received $2,322,500 of gross proceeds and converted $223,000 of accrued liabilities from related parties, including board members, and issued 33,940,000 shares of common stock.

Medite Cancer Diagnostics, Inc. 10-Q